190 related articles for article (PubMed ID: 38085800)
1. Transgenic amyloid precursor protein mouse models of amyloidosis. Incomplete models for Alzheimer's disease but effective predictors of anti-amyloid therapies.
Morgan DG; Lamb BT
Alzheimers Dement; 2024 Feb; 20(2):1459-1464. PubMed ID: 38085800
[TBL] [Abstract][Full Text] [Related]
2. Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia.
Xia D; Lianoglou S; Sandmann T; Calvert M; Suh JH; Thomsen E; Dugas J; Pizzo ME; DeVos SL; Earr TK; Lin CC; Davis S; Ha C; Leung AW; Nguyen H; Chau R; Yulyaningsih E; Lopez I; Solanoy H; Masoud ST; Liang CC; Lin K; Astarita G; Khoury N; Zuchero JY; Thorne RG; Shen K; Miller S; Palop JJ; Garceau D; Sasner M; Whitesell JD; Harris JA; Hummel S; Gnörich J; Wind K; Kunze L; Zatcepin A; Brendel M; Willem M; Haass C; Barnett D; Zimmer TS; Orr AG; Scearce-Levie K; Lewcock JW; Di Paolo G; Sanchez PE
Mol Neurodegener; 2022 Jun; 17(1):41. PubMed ID: 35690868
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
[TBL] [Abstract][Full Text] [Related]
5. Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice.
Steffen J; Krohn M; Schwitlick C; Brüning T; Paarmann K; Pietrzik CU; Biverstål H; Jansone B; Langer O; Pahnke J
Acta Neuropathol Commun; 2017 Jun; 5(1):49. PubMed ID: 28637503
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease.
Dikranian K; Kim J; Stewart FR; Levy MA; Holtzman DM
Int J Clin Exp Pathol; 2012; 5(6):482-95. PubMed ID: 22949930
[TBL] [Abstract][Full Text] [Related]
7. Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage.
Villarreal S; Zhao F; Hyde LA; Holder D; Forest T; Sondey M; Chen X; Sur C; Parker EM; Kennedy ME
J Alzheimers Dis; 2017; 59(4):1393-1413. PubMed ID: 28800329
[TBL] [Abstract][Full Text] [Related]
8. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
Lecordier S; Pons V; Rivest S; ElAli A
Front Immunol; 2021; 12():813536. PubMed ID: 35173711
[TBL] [Abstract][Full Text] [Related]
9. APP transgenic mouse models and their use in drug discovery to evaluate amyloid- lowering therapeutics.
Hussain I
CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):395-402. PubMed ID: 20522015
[TBL] [Abstract][Full Text] [Related]
10. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
11. Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease.
Dodson SE; Andersen OM; Karmali V; Fritz JJ; Cheng D; Peng J; Levey AI; Willnow TE; Lah JJ
J Neurosci; 2008 Nov; 28(48):12877-86. PubMed ID: 19036982
[TBL] [Abstract][Full Text] [Related]
12. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis.
Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer's disease mutations but not by inhibition of BACE1.
Johnson ECB; Ho K; Yu GQ; Das M; Sanchez PE; Djukic B; Lopez I; Yu X; Gill M; Zhang W; Paz JT; Palop JJ; Mucke L
Mol Neurodegener; 2020 Sep; 15(1):53. PubMed ID: 32921309
[TBL] [Abstract][Full Text] [Related]
14. Altered dynamics of glymphatic flow in a mature-onset Tet-off APP mouse model of amyloidosis.
Ben-Nejma IRH; Keliris AJ; Vanreusel V; Ponsaerts P; Van der Linden A; Keliris GA
Alzheimers Res Ther; 2023 Jan; 15(1):23. PubMed ID: 36707887
[TBL] [Abstract][Full Text] [Related]
15. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
16. Cross-species genetic screens to identify kinase targets for APP reduction in Alzheimer's disease.
Huichalaf CH; Al-Ramahi I; Park KW; Grunke SD; Lu N; de Haro M; El-Zein K; Gallego-Flores T; Perez AM; Jung SY; Botas J; Zoghbi HY; Jankowsky JL
Hum Mol Genet; 2019 Jun; 28(12):2014-2029. PubMed ID: 30753434
[TBL] [Abstract][Full Text] [Related]
17. A CHCHD6-APP axis connects amyloid and mitochondrial pathology in Alzheimer's disease.
Shang Y; Sun X; Chen X; Wang Q; Wang EJ; Miller E; Xu R; Pieper AA; Qi X
Acta Neuropathol; 2022 Nov; 144(5):911-938. PubMed ID: 36104602
[TBL] [Abstract][Full Text] [Related]
18. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
19. Anti-ApoE antibody given after plaque onset decreases Aβ accumulation and improves brain function in a mouse model of Aβ amyloidosis.
Liao F; Hori Y; Hudry E; Bauer AQ; Jiang H; Mahan TE; Lefton KB; Zhang TJ; Dearborn JT; Kim J; Culver JP; Betensky R; Wozniak DF; Hyman BT; Holtzman DM
J Neurosci; 2014 May; 34(21):7281-92. PubMed ID: 24849360
[TBL] [Abstract][Full Text] [Related]
20. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
Liu HL; Zhao G; Zhang H; Shi LD
Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
